Literature DB >> 18259004

Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Babbette D LaMarca1, Jeffery Gilbert, Joey P Granger.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18259004      PMCID： PMC2782443          DOI： 10.1161/HYPERTENSIONAHA.107.108837

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  110 in total

1.  Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia.

Authors:  J T Murai; E Muzykanskiy; R N Taylor
Journal:  Metabolism       Date:  1997-08       Impact factor: 8.694

Review 2.  Hypertension during pregnancy: a disorder begging for pathophysiological support.

Authors:  Ravi I Thadhani; Richard J Johnson; S Ananth Karumanchi
Journal:  Hypertension       Date:  2005-10-24       Impact factor: 10.190

3.  Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.

Authors:  N Sattar; I A Greer; J Louden; G Lindsay; M McConnell; J Shepherd; C J Packard
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

4.  Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study.

Authors:  Giorgio Mello; Elena Parretti; Luca Marozio; Cristina Pizzi; Andrea Lojacono; Tiziana Frusca; Fabio Facchinetti; Chiara Benedetto
Journal:  Hypertension       Date:  2005-10-24       Impact factor: 10.190

Review 5.  Placental cytokines and the pathogenesis of preeclampsia.

Authors:  K P Conrad; D F Benyo
Journal:  Am J Reprod Immunol       Date:  1997-03       Impact factor: 3.886

Review 6.  Preeclampsia: recent insights.

Authors:  James M Roberts; Hilary S Gammill
Journal:  Hypertension       Date:  2005-10-17       Impact factor: 10.190

7.  Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants.

Authors:  Paul D Speer; Robert W Powers; Michael P Frank; Gail Harger; Nina Markovic; James M Roberts
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

8.  Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression.

Authors:  Jeffrey S Gilbert; Sara A Babcock; Joey P Granger
Journal:  Hypertension       Date:  2007-10-08       Impact factor: 10.190

Review 9.  Plasma lipids and vascular dysfunction in preeclampsia.

Authors:  B Lorentzen; T Henriksen
Journal:  Semin Reprod Endocrinol       Date:  1998

Review 10.  Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia.

Authors:  R N Taylor; C J de Groot; Y K Cho; K H Lim
Journal:  Semin Reprod Endocrinol       Date:  1998
View more
  61 in total

1.  Normal pregnancy: mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure.

Authors:  Brandiese E Jacobs; Yong Liu; Maria V Pulina; Vera A Golovina; John M Hamlyn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-13       Impact factor: 4.733

2.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

3.  Alterations in maternal and fetal heart functions accompany failed spiral arterial remodeling in pregnant mice.

Authors:  Jianhong Zhang; Michael A Adams; B Anne Croy
Journal:  Am J Obstet Gynecol       Date:  2011-06-12       Impact factor: 8.661

4.  Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats.

Authors:  Denise C Cornelius; Javier Castillo; Justin Porter; Lorena M Amaral; Nathan Campbell; Adrienne Paige; Alexia J Thomas; Ashlyn Harmon; Mark W Cunningham; Kedra Wallace; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

5.  Is maternal blood pressure the key to vascular dysfunction in preterm offspring with elevated blood pressure?

Authors:  Barbara T Alexander
Journal:  Hypertension       Date:  2010-05-17       Impact factor: 10.190

6.  The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.

Authors:  M Cheng; P He; J Fu
Journal:  J Hum Hypertens       Date:  2016-05-12       Impact factor: 3.012

7.  Effects of maternal serum on permeability of glomerular endothelial cell membrane.

Authors:  Hui Du; Haiyi Liu; Jun Zhao; Yuanyuan Wu; Xun Gong; Qiong Zhou; Jingjing Xu; Yuqi Li; Xinwei Shi; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

8.  Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat.

Authors:  Jeffrey S Gilbert; Christopher T Banek; Ashley J Bauer; Anne Gingery; Karen Needham
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

9.  Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.

Authors:  Justin Brewer; Ruisheng Liu; Yan Lu; Jeremy Scott; Kedra Wallace; Gerd Wallukat; Janae Moseley; Florian Herse; Ralf Dechend; James N Martin; Babbette Lamarca
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.